Navigation Links
Hospital to Hold MRSA Briefing for Media and Community Leaders
Date:10/30/2007

Dr. James Rahal, Infectious Disease Specialist, also available as Expert Resource

FLUSHING, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The following is being issued by New York Hospital Queens:

WHAT: A special briefing on methicillin-resistant Staphylococcus

aureus(MRSA) is scheduled for media and community leaders.

James Rahal, M.D., and a team of infectious disease

specialists from New York Hospital Queens will address the

basis of concern about this infection. They will discuss the

risks, and address the fear caused by recent cases of

community-acquired MRSA infection in the New York area.

During the briefing, the date and location of a community

education program is expected to be announced.

WHEN: Thursday, November 1, 2007 at 10 a.m.

WHERE: New York Hospital Queens 56-45 Main Street, Flushing NY

11355

Lang Auditorium (please leave 15 minutes for access from

parking area)

FYI: Methicillin-resistant Staphylococcus aureus (MRSA) is a type

of Staph that is resistant to commonly used antibiotics. MRSA

infections occur most frequently among persons in hospitals

and healthcare facilities (such as nursing homes and dialysis

centers) who have weakened immune systems.

MRSA infections that are acquired by healthy persons in the

community who have not been recently (within the past year)

hospitalized or had a medical procedure are known as

Community Acquired-MRSA infections (CA-MRSA). These CA-MRSA

infections are usually manifested as skin infections, such as

pimples, boils, or abscesses; and rarely, pneumonia. For

background on healthcare and community-acquired infections,

as well as infection control guidance, including in school

settings, go to http://www.cdc.gov/ncidod.

NYHQ conducts ongoing surveillance for infectious diseases,

as well as targeted research. An original article based upon

a multi-year investigation into the impact on MRSA is being

published in the November issue of the journal Infection

Control and Hospital Epidemiology.

CONTACT: Cynthia Bacon

(718) 670-2515


'/>"/>
SOURCE New York Hospital Queens
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
6. Six Important Things to Know About Preventing Hospital Infections
7. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
8. Hospitalization Rates for Coronary Artery Disease Decline in the U.S.
9. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
10. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
11. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... 2017  New York City-based market research firm Kalorama Information ... aware of.  From new products to new costs, to the ... recently completed study, Potential Pipeline Disruptors . ... 1.  Age-Driven Growth - True Impact Moment Arriving ... the impact the growing population and, to a more extreme ...
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
Breaking Medicine Technology:
(Date:7/24/2017)... TX (PRWEB) , ... July 24, 2017 , ... ... under the federal Substance Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted ... of California Department of Health Care Services, will facilitate the development of a ...
(Date:7/24/2017)... ... 24, 2017 , ... A four alarm fire in an ... threatened numerous homes and businesses nearby, causing some 700 individuals to be evacuated, ... Area consulting firm Fire Protection Group, Inc. notes that the report is a ...
(Date:7/24/2017)... ... 24, 2017 , ... The International Essential Tremor Foundation (IETF) will host a ... (ET). The seminar will take place on Saturday, Aug. 26 at the Embassy Suites ... will run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. ...
(Date:7/24/2017)... ... July 24, 2017 , ... Axiad IDS , a leading ... has partnered with WALLIX to expand its solution to help government contractors ... are a number of ways to address the authentication requirements within NIST SP800-171, ...
(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
Breaking Medicine News(10 mins):